"Cancer survivors know that a diagnosis is just a start of a journey. If you or someone you love is on that path, the NorthBay Cancer Center Team is here for you, with cutting-edge treatment, outstanding physicians, compassionate and qualified nurses to help you navigate the system, clinical trials and more."

During the past decade, Northbay Cancer Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 24 clinical trials were completed, i.e. on average, 96% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 17 clinical trials were completed. i.e. 242.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northbay Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northbay Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Northbay Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "HER2/Neu Negative" (3 trials) and "Invasive Breast Carcinoma" (3 trials). Many other conditions were trialed in "Northbay Cancer Center" in a lesser frequency.

Most popular intervention types in "Northbay Cancer Center" are "Drug" (38 trials), "Other" (33 trials), "Biological" (16 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (12 trials), "Docetaxel" (8 trials), "Bevacizumab" (6 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Northbay Cancer Center" are 30 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Northbay Cancer Center". undefined are not yet recruiting, 8 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Northbay Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northbay Cancer Center, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".